Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC2545087- UniProt (similar protein)
P01631- Tanimoto
- 1.000
- Target protein
- A0A075B6I6
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 112.7
- −1 ≤ LogP ≤ 5 1.77
- MW ≤ 500 Da 379.5
- LogP ≤ 5 1.77
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 9
- TPSA ≤ 140 Ų 112.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CN(C)c1cccc2c(S(=O)(=O)NCCCC[C@H](N)C(=O)O)cccc12CN(C)c1cccc2c(S(=O)(=O)NCCCC[C@H](N)C(=O)O)cccc12
InChI=1S/C18H25N3O4S/c1-21(2)16-10-5-8-14-13(16)7-6-11-17(14)26(24,25)20-12-4-3-9-15(19)18(22)23/h5-8,10-11,15,20H,3-4,9,12,19H2,1-2H3,(H,22,23)/t15-/m0/s1InChI=1S/C18H25N3O4S/c1-21(2)16-10-5-8-14-13(16)7-6-11-17(14)26(24,25)20-12-4-3-9-15(19)18(22)23/h5-8,10-11,15,20H,3-4,9,12,19H2,1-2H3,(H,22,23)/t15-/m0/s1
VQPRNSWQIAHPMS-HNNXBMFYSA-NVQPRNSWQIAHPMS-HNNXBMFYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ domain
- Query
- DNS
- Homolog
- P01631
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC2545087 →
- ZINC ZINC20 ZINC2545087 →
- UniProt UniProt P01631 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC2545087”) →
Other ligands for this protein
Quick navigation to other ligands bound to A0A075B6I6.
PDB 55
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 29
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).